Addus HomeCare (NASDAQ:ADUS) Given Market Outperform Rating at JMP Securities

JMP Securities reiterated their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS - Free Report) in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $150.00 price target on the stock.

ADUS has been the topic of several other reports. Stephens reissued an "overweight" rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. StockNews.com cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research report on Wednesday, February 26th. Macquarie reissued an "outperform" rating and issued a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. Finally, Oppenheimer upped their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $139.00.

Addus HomeCare Price Performance

Addus HomeCare stock traded up $1.04 during midday trading on Tuesday, hitting $100.58. The company's stock had a trading volume of 97,408 shares, compared to its average volume of 162,804. The company has a market cap of $1.83 billion, a price-to-earnings ratio of 23.02, a PEG ratio of 1.41 and a beta of 0.93. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72. The company has a 50-day moving average price of $97.93 and a two-hundred day moving average price of $116.06.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share for the quarter, missing analysts' consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Sell-side analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently made changes to their positions in the stock. JPMorgan Chase & Co. boosted its position in Addus HomeCare by 10.2% in the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company's stock valued at $24,371,000 after buying an additional 16,997 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company's stock valued at $67,293,000 after acquiring an additional 75,409 shares during the last quarter. Cherry Creek Investment Advisors Inc. acquired a new stake in shares of Addus HomeCare during the 4th quarter valued at $340,000. Amundi grew its position in Addus HomeCare by 185.9% during the 4th quarter. Amundi now owns 9,008 shares of the company's stock worth $1,139,000 after acquiring an additional 5,857 shares during the last quarter. Finally, Barclays PLC increased its holdings in Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company's stock worth $5,783,000 after purchasing an additional 29,207 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.